You have 9 free searches left this month | for more free features.

Targeted Lung Denervation

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COPD Trial (Targeted Lung Denervation)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • Targeted Lung Denervation
  • (no location specified)
Jul 21, 2023

Hyperpolarized Xenon Functional Lung Imaging in COPD Patients

Not yet recruiting
  • COPD
  • Functional imaging of the lungs using MagniXene (hyperpolarized xenon-129) MRI
  • (no location specified)
Apr 3, 2023

COPD Trial in Chengdu (TLD, Sham TLD procedure, Standard of care)

Not yet recruiting
  • COPD
  • TLD
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Apr 3, 2023

COPD Trial in Worldwide (Targeted Lung Denervation (TLD), Optimal Medical Care)

Recruiting
  • COPD
  • Targeted Lung Denervation (TLD)
  • Optimal Medical Care
  • Birmingham, Alabama
  • +32 more
May 9, 2022

Participants Undergoing Targeted Lung Health Checks

Not yet recruiting
  • Lung Cancer
    • London, United Kingdom
      University College London Hospitals NHS Foundation Trust
    Jun 5, 2023

    Efficacy of Targeted Therapy for NSCLC

    Recruiting
    • Evaluation
    • +2 more
    • RecistTM criteria
    • Chongqing, Chongqing, China
      Cancer Center, Dapping Hospital, Army Medical Center of PLA
    Nov 15, 2023

    Results of Specific Gene Testing and Efficacy of Targeted

    Completed
    • Non Small Cell Lung Cancer
      • Changsha, Hunan, China
        Hunan Cancer hospital
      Mar 27, 2023

      Specific Genetic Tests and Efficacy of Targeted Therapies in

      Recruiting
      • Non-small Cell Lung Cancer
        • Changsha, Hunan, China
          Hunan Cancer hospital
        Dec 26, 2022

        Peripheral Lung Tumor Trial (Padeliporfin Vascular Targeted Photodynamic (VTP) therapy)

        Not yet recruiting
        • Peripheral Lung Tumor
        • Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
        • (no location specified)
        Jun 15, 2023

        Lung Cancer, Lung Metastases Trial in Orlando (VGT-309)

        Recruiting
        • Lung Cancer
        • Lung Metastases
        • Orlando, Florida
          Orlando Health Cancer Institute
        Nov 22, 2023

        Interstitial Lung Disease Trial in Boston ([68Ga]CBP8, Dotarem)

        Recruiting
        • Interstitial Lung Disease
        • Boston, Massachusetts
          Massachusetts General Hospital
        Aug 22, 2022

        NSCLC Trial (disease self-management application)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • disease self-management application
        • (no location specified)
        Nov 9, 2022

        Non Small Cell Lung Cancer Trial (Osimertinib Mesylate)

        Not yet recruiting
        • Non Small Cell Lung Cancer
        • Osimertinib Mesylate
        • (no location specified)
        May 18, 2022

        NSCLC, BRAF V600 Mutation, MET Exon 14 Mutation Trial in Guangzhou (Dabrafenib + Trametinib, Capmatinib)

        Not yet recruiting
        • NSCLC
        • +2 more
        • Guangzhou, Guangdong, China
          Cancer Center of Sun-Yat Sen University
        Sep 19, 2023

        NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

        Active, not recruiting
        • Carcinoma, Non-Small-Cell Lung
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Aug 24, 2022

        Lung Cancer, EGFR Gene Mutation, EGFR Trial in Charlottesville (Sensus Smartwatch Application, RX Cap, Fitbit Sense)

        Recruiting
        • Lung Cancer
        • +3 more
        • Sensus Smartwatch Application
        • +3 more
        • Charlottesville, Virginia
          University of Virginia
        Aug 26, 2022

        COPD Exacerbation, COPD Exacerbation Acute Trial (Titrated Oxygen, Standard Oxygen)

        Not yet recruiting
        • COPD Exacerbation
        • COPD Exacerbation Acute
        • Titrated Oxygen
        • Standard Oxygen
        • (no location specified)
        Feb 2, 2023

        NSCLC, EGF-R Positive NSCLC Trial in Wuxi (Parimparib, Chemotherapy drug, Targeted Therapy Agent)

        Recruiting
        • Carcinoma, Non-Small-Cell Lung
        • EGF-R Positive Non-Small Cell Lung Cancer
        • Wuxi, Jiangsu, China
          Affiliated Hospital of Jiangnan University
        Jan 30, 2023

        Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)

        Not yet recruiting
        • Lung Non-Small Cell Carcinoma
        • Amivantamab
        • +3 more
        • (no location specified)
        Oct 30, 2023

        Sleep Disturbance, Inflammation, Quality of Life Trial in Chicago (Targeted Cognitive Behavior Therapy for Insomnia,

        Recruiting
        • Sleep Disturbance
        • +4 more
        • Targeted Cognitive Behavior Therapy for Insomnia
        • Information-Only Control
        • Chicago, Illinois
          Northwestern University Feinberg School of Medicine
        Mar 27, 2023

        NSCLC, Primary Tumor Trial in Hamilton (Synapse 3D Lung Modelling, IC-Green (ICG))

        Recruiting
        • Non-small Cell Lung Cancer
        • Primary Neoplasm
        • Synapse 3D Lung Modelling
        • IC-Green (ICG)
        • Hamilton, Ontario, Canada
          St. Josephs Healthcare Hamilton
        Jan 23, 2023

        Molecular Analysis and Treatment Options of SCLC

        Recruiting
        • Small-cell Lung Cancer
        • +4 more
        • Shanghai, China
          Shanghai Chest Hospital
        Jul 6, 2023

        Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Taiyuan (CEA-targeted CAR-T cells)

        Recruiting
        • Gastric Cancer
        • +6 more
        • CEA-targeted CAR-T cells
        • Taiyuan, Shanxi, China
        • +1 more
        Aug 24, 2023

        Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Wuhu (CEA-targeted CAR-T cells)

        Recruiting
        • Gastric Cancer
        • +7 more
        • CEA-targeted CAR-T cells
        • Wuhu, Anhui, China
          The First Affiliated Hospital of Wannan Medical College
        Nov 9, 2023

        Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

        Not yet recruiting
        • Recurrent Lung Non-Small Cell Carcinoma
        • Stage IV Lung Cancer AJCC v8
        • Biospecimen Collection
        • +5 more
        • (no location specified)
        Sep 7, 2023